Incorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design
J German(New York Blood Center), Andrea Ganna(Broad Institute), Zhiyu Yang(University of Helsinki), Sarah Urbut(Massachusetts General Hospital), Pradeep Natarajan(Unknown), Zoltán Kutalik(SIB Swiss Institute of Bioinformatics), Pekka Vartiainen(Norwegian Institute of Public Health), Anthony Philippakis(Broad Institute)
Cited by 4
Related Papers
Analysis of protein-coding genetic variation in 60,706 humans
|Nature|2016|10.3k
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
|Nature Genetics|2018|3.1k
The mutational constraint spectrum quantified from variation in 141,456 humans
|bioRxiv (Cold Spring Harbor Laboratory)|2019|1.8k
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k